Author:
Mehendale Sanjay,Thakar Madhuri,Sahay Seema,Kumar Makesh,Shete Ashwini,Sathyamurthi Pattabiraman,Verma Amita,Kurle Swarali,Shrotri Aparna,Gilmour Jill,Goyal Rajat,Dally Len,Sayeed Eddy,Zachariah Devika,Ackland James,Kochhar Sonali,Cox Josephine H.,Excler Jean-Louis,Kumaraswami Vasanthapuram,Paranjape Ramesh,Ramanathan Vadakkuppatu Devasenapathi
Publisher
Public Library of Science (PLoS)
Reference58 articles.
1. National AIDS Control Programme(2011). Response to the HIV Epidemic in India. Available: http://www.nacoonline.org/upload/IEC%20Division/Parliamentarian%20Forum%204-5%20july%202011/NACO%20Monograp%20NACP.pdf. Accessed 2012 November 2.
2. Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India;S Mehendale;Indian J Med Res,2010
3. A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine;S Mehendale;AIDS Res Hum Retroviruses,2008
4. A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers;VD Ramanathan;AIDS Res Hum Retroviruses,2009
5. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection;NM Flynn;J Infect Dis,2005
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献